EDSS

Related by string. Eds. . eds. . Edser * * Scale EDSS . EDSS score . EDSS scores . Status Scale EDSS . Scale EDSS score *

Related by context. Frequent words. (Click for all words.) 59 LVEF 58 ACR# [002] 58 symptom severity 58 mg BID 57 QoL 57 tiotropium 56 adalimumab 56 rotigotine 56 clinically meaningful 55 HbA1c levels 55 placebo p = 55 fasting plasma glucose 55 RECIST criteria 55 pramipexole 54 microalbuminuria 54 RECIST 54 quetiapine 54 secondary endpoint 53 HbA1c 53 Secondary endpoints 53 preoperatively 53 etanercept 53 free survival PFS 53 ACTEMRA 53 52 clinical endpoints 52 lacosamide 52 median PFS 52 nonsignificant 52 Secondary endpoints included 52 P = .# 52 fingolimod 52 p = #.# [002] 52 dyspnea 51 composite endpoint 51 evaluable patients 51 undetectable viral load 51 abatacept 51 lung function 51 eGFR 51 mg doses 51 mg dose 51 % CI #.#-#.# [006] 51 proteinuria 51 glimepiride 50 postoperatively 50 statistically significant improvement 50 bosentan 50 creatinine clearance 50 febrile neutropenia 50 evaluable 50 p = #.# [004] 50 placebo 50 laboratory abnormalities 50 events AEs 50 pulmonary function 49 relapsing remitting 49 comorbid conditions 49 statistical significance 49 p = 49 tumor shrinkage 49 visual acuity 49 A1C levels 49 Median survival 49 confidence interval CI 49 FOLFOX 49 mcg kg 49 primary efficacy endpoint 49 fasting blood glucose 48 certolizumab pegol 48 seroconversion 48 Secondary endpoints include 48 pioglitazone 48 glomerular filtration rate 48 statistically significant 48 primary endpoint 48 sustained virologic response 48 TIMI 48 PASI 48 treatment emergent adverse 48 echocardiographic 48 tumor recurrence 48 peginterferon alfa 2a 48 demonstrated statistically significant 48 placebo p 48 mitoxantrone 48 titers 47 clinically relevant 47 histologic 47 disease progression 47 oral glucose tolerance 47 serum creatinine 47 insulin glargine 47 IU mL 47 depressive symptoms 47 ADHD symptoms 47 monotherapy 47 statistically significant p 47 arterial stiffness 47 fibrosis 47 ejection fraction

Back to home page